# Mineralys Therapeutics Inc. (MLYS)

Source: https://www.quantisnow.com/company/MLYS
Generated: 2026-11-10T09:51:27.415Z

- Ticker: MLYS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2023
- SEC CIK: 0001933414

## Latest MLYS news and filings

- 2026-11-08 21:35 UTC [Mineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat in Hypertension at AHA Scientific Sessions 2026](https://www.quantisnow.com/insight/mineralys-therapeutics-presents-new-late-breaking-data-from-transform-htn-open-label-extension-6779802)
- 2026-11-06 13:00 UTC [Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)](https://www.quantisnow.com/insight/mineralys-therapeutics-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-6778061)
- 2026-11-04 22:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-mineralys-therapeutics-inc-6773577)
- 2026-11-04 21:08 UTC [SEC Form 8-K] [Mineralys Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mineralys-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6772541)
- 2026-11-04 21:05 UTC [Earnings] [Mineralys Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update](https://www.quantisnow.com/insight/mineralys-therapeutics-reports-third-quarter-2026-financial-results-and-provides-6772280)
- 2026-11-03 21:05 UTC [Conference Announcement] [Mineralys Therapeutics to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/mineralys-therapeutics-to-participate-in-upcoming-investor-conferences-6769469)
- 2026-10-29 20:08 UTC [SEC Form 8-K] [SEC Form 8-K filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-mineralys-therapeutics-inc-6763559)
- 2026-10-28 20:05 UTC [Earnings Date] [Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026](https://www.quantisnow.com/insight/mineralys-therapeutics-to-announce-third-quarter-2026-financial-results-and-6761153)
- 2026-10-28 11:05 UTC [Mineralys Therapeutics Announces Publication of Phase 2 Explore-CKD Trial Results for Lorundrostat in Kidney International](https://www.quantisnow.com/insight/mineralys-therapeutics-announces-publication-of-phase-2-explore-ckd-trial-results-6760447)
- 2026-10-22 22:40 UTC [Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026](https://www.quantisnow.com/insight/mineralys-therapeutics-presents-new-lorundrostat-data-in-participants-with-hypertension-6755606)
- 2026-10-20 21:35 UTC [SEC Form 4] [SEC Form 4 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-mineralys-therapeutics-inc-6752488)
- 2026-10-20 21:33 UTC [SEC Form 3] [SEC Form 3 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-mineralys-therapeutics-inc-6752487)
- 2026-10-20 21:32 UTC [SEC Form 4] [SEC Form 4 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-mineralys-therapeutics-inc-6752485)
- 2026-10-20 21:30 UTC [SEC Form 3] [SEC Form 3 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-mineralys-therapeutics-inc-6752481)
- 2026-10-19 20:37 UTC [SEC Form 8-K] [SEC Form 8-K filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-mineralys-therapeutics-inc-6750835)
- 2026-10-19 20:05 UTC [Leadership Update] [Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats](https://www.quantisnow.com/insight/mineralys-therapeutics-expands-its-board-of-directors-with-the-appointments-6750498)
- 2026-10-13 20:11 UTC [SEC Form 144] [SEC Form 144 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-mineralys-therapeutics-inc-6745040)
- 2026-10-12 12:51 UTC [Analyst Coverage Initiated] [UBS initiated coverage on Mineralys Therapeutics with a new price target](https://www.quantisnow.com/insight/ubs-initiated-coverage-on-mineralys-therapeutics-with-a-new-price-6743593)
- 2026-10-09 13:00 UTC [Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026](https://www.quantisnow.com/insight/mineralys-therapeutics-presents-new-data-for-lorundrostat-at-the-american-6742539)
- 2026-10-02 21:53 UTC [SEC Form 4] [Chief Executive Officer Congleton Jon sold $1,909,665 worth of shares (75,000 units at $25.46) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 528,621 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-congleton-jon-sold-1909665-worth-of-shares-6735417)
- 2026-10-02 20:30 UTC [Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026](https://www.quantisnow.com/insight/mineralys-therapeutics-announces-presentation-of-new-lorundrostat-data-at-the-6734778)
- 2026-10-01 20:05 UTC [Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026](https://www.quantisnow.com/insight/mineralys-therapeutics-announces-presentation-of-lorundrostat-data-at-american-heart-6732331)
- 2026-09-30 20:07 UTC [SEC Form 144] [SEC Form 144 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-mineralys-therapeutics-inc-6730615)
- 2026-09-29 20:05 UTC [Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)](https://www.quantisnow.com/insight/mineralys-therapeutics-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-6729168)
- 2026-09-25 01:49 UTC [SEC Form 4] [Director Slingsby Brian Taylor sold $3,005,303 worth of shares (104,320 units at $28.81) (SEC Form 4)](https://www.quantisnow.com/insight/director-slingsby-brian-taylor-sold-3005303-worth-of-shares-104320-6725879)
- 2026-09-24 20:05 UTC [Conference Announcement] [Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum](https://www.quantisnow.com/insight/mineralys-therapeutics-to-participate-in-the-stifel-2026-virtual-cardiometabolic-6725344)
- 2026-09-22 22:48 UTC [SEC Form 4] [Chief Commercial Officer Warren Eric exercised 7,438 shares at a strike of $13.24 and sold $209,136 worth of shares (7,438 units at $28.12) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-commercial-officer-warren-eric-exercised-7438-shares-at-a-6723365)
- 2026-09-22 20:09 UTC [SEC Form 144] [SEC Form 144 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-mineralys-therapeutics-inc-6722986)
- 2026-09-21 20:05 UTC [SEC Form 144] [SEC Form 144 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-mineralys-therapeutics-inc-6721622)
- 2026-09-21 20:05 UTC [Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)](https://www.quantisnow.com/insight/mineralys-therapeutics-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-6721603)
- 2026-09-17 21:41 UTC [SEC Form 4] [Director Karydas Daphne exercised 3,000 shares at a strike of $12.02 and sold $85,740 worth of shares (3,000 units at $28.58) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/director-karydas-daphne-exercised-3000-shares-at-a-strike-of-6719669)
- 2026-09-17 20:06 UTC [SEC Form 144] [SEC Form 144 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-mineralys-therapeutics-inc-6719102)
- 2026-09-15 20:19 UTC [SEC Form 144] [SEC Form 144 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-mineralys-therapeutics-inc-6716200)
- 2026-09-14 20:06 UTC [SEC Form 144] [SEC Form 144 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-mineralys-therapeutics-inc-6714440)
- 2026-09-09 20:05 UTC [SEC Form 144] [SEC Form 144 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-mineralys-therapeutics-inc-6709983)
- 2026-09-09 20:05 UTC [Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)](https://www.quantisnow.com/insight/mineralys-therapeutics-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-6709939)
- 2026-08-26 12:00 UTC [Conference Announcement] [Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference](https://www.quantisnow.com/insight/mineralys-therapeutics-to-participate-in-the-wells-fargo-21st-annual-6694999)
- 2026-08-25 21:16 UTC [SEC Form 4] [Chief Commercial Officer Warren Eric exercised 7,437 shares at a strike of $13.24 and sold $193,189 worth of shares (7,437 units at $25.98) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-commercial-officer-warren-eric-exercised-7437-shares-at-a-6694610)
- 2026-08-21 20:14 UTC [SEC Form 144] [SEC Form 144 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-mineralys-therapeutics-inc-6691361)
- 2026-08-17 20:38 UTC [SEC Form 144] [SEC Form 144 filed by Mineralys Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-mineralys-therapeutics-inc-6685210)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MLYS
- Earnings history: https://www.quantisnow.com/earnings/MLYS
- Dividend history: https://www.quantisnow.com/dividends/MLYS
- Insider transactions: https://www.quantisnow.com/insiders/MLYS
- Options chain: https://www.quantisnow.com/options/MLYS
- SEC 8-K filings only: https://www.quantisnow.com/company/MLYS/8-k
- RSS and alerts for MLYS: https://www.quantisnow.com/docs/rss-feeds.md